What aspect of clinical trials does GCP primarily focus on?

Good Clinical Practice (GCP) primarily focuses on the ethical and scientific quality of clinical trials. This framework was established to ensure that the rights and safety of trial participants are protected and that the data generated from clinical trials is credible and reliable.

GCP outlines responsibilities for various stakeholders involved in the clinical research process, including sponsors, investigators, and ethics committees, ensuring that clinical trials are conducted in accordance with ethical principles. This includes obtaining informed consent from participants, ensuring patient welfare, and adhering to scientific and regulatory standards throughout the study. By emphasizing these ethical and scientific aspects, GCP helps to maintain public trust in the research process and safeguard participant welfare while generating accurate data that can be used to advance medical knowledge and treatment options.

In contrast, while monetary investment, speed of execution, and marketing of results are important considerations in the conduct of clinical trials, they do not encompass the primary focus of GCP, which is dedicated to ethical conduct and scientific integrity.